Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Dallas, Madison, Portland, Salt Lake City
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleFlorida Center for Brain Tumor Research
- Where
- Gainesville
- People
- 4,000
- Run by
- University of Florida
See details and how to joinNCT00811148 - Phase 1/2Taking peopleRetifanlimab and Ruxolitinib In Solid Malignancies
- Where
- La Jolla
- People
- 40
- Run by
- University of California, San Diego
See details and how to joinNCT07219576 - No phaseTaking peopleEvaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
- Where
- Rochester
- People
- 110
- Run by
- Mayo Clinic
See details and how to joinNCT07335315 - No phaseTaking peopleRegistry to Collect Health Information About Desmoplastic Small Round Cell Tumor
- Where
- New York
- People
- 250
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04690374 - Phase 1Taking peopleVenetoclax to Augment Epigenetic Modification and Chemotherapy
- Where
- Milwaukee
- Age
- 1 year to 25 years
- People
- 40
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05317403 - No phaseTaking peopleNon-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
- Where
- Dallas
- People
- 25
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06353321 - Phase 1Taking peopleStem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
- Where
- Palo Alto
- Age
- 1 month to 45 years
- People
- 22
- Run by
- Porteus, Matthew, MD
See details and how to joinNCT04640987 - Phase 1Taking peoplePharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Where
- Atlanta, New York
- Age
- 12 years and over
- People
- 50
- Run by
- Meryx, Inc.
See details and how to joinNCT04872478 - Phase 2Taking peopleLinvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
- Where
- Miami
- People
- 32
- Run by
- Dickran Kazandjian, MD
See details and how to joinNCT06910124 - No phaseTaking peoplePharmacokinetics of Drugs Administered to Children
- Where
- Durham
- Age
- 0 years to 20 years
- People
- 200
- Run by
- Duke University
See details and how to joinNCT03481881 - No phaseTaking peopleOptimizing the AYA Survivors' Coping and Emotional Needs Toolkit
- Where
- Greenville, Winston-Salem
- Age
- 15 years to 39 years
- People
- 208
- Run by
- East Carolina University
See details and how to joinNCT07173205 - No phaseTaking peopleSurvivors Journey+
- Where
- Cincinnati, Columbus
- Age
- 15 years to 25 years
- People
- 72
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT07321353 - No phaseNot yet taking people in United StatesGenetic Investigation of Cancer Predisposition
- Where
- San Antonio
- People
- 100
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT04620278 - No phaseTaking peopleDigital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
- Where
- Palo Alto
- Age
- 10 years to 25 years
- People
- 25
- Run by
- Stanford University
See details and how to joinNCT07220343 - No phaseTaking peoplePromoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
- Where
- Boston
- Age
- 12 years to 25 years
- People
- 325
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06038318 - No phaseEnrolling by invitationHead-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
- Where
- Boston
- People
- 30
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07307157 - Phase 1Taking peopleAllogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Where
- Atlanta
- Age
- 12 months and over
- People
- 24
- Run by
- Emory University
See details and how to joinNCT05400603 - Phase 1/2Taking peopleStudy of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
- Where
- Boston
- Age
- 12 months to 29 years
- People
- 42
- Run by
- Roberto Chiarle
See details and how to joinNCT06803875 - No phaseTaking peopleThe Ohio State University (OSU) SCREEN Community Program
- Where
- Columbus
- People
- 2,067
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT06666192 - Phase 1Taking peoplePLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML
- Where
- Seattle
- Age
- Up to 30 years
- People
- 18
- Run by
- Seattle Children's Hospital
See details and how to joinNCT05105152 - No phaseTaking peopleMetabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
- Where
- Baltimore
- People
- 24
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07032545 - No phaseTaking peopleTissue Collection for Drug Screening and Bioanalysis
- Where
- New York
- People
- 500
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT04852354 - Phase 2Taking peopleA Study of Emapalumab for Pediatric Aplastic Anemia
- Where
- Cincinnati, Milwaukee, New York, Philadelphia, Richmond
- Age
- 0 years to 25 years
- People
- 35
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06430788 - No phaseTaking peopleDiscovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 1,500
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03922893